Stockreport

REGN's EYLEA HD Improves Vision in RVO Patients [Yahoo! Finance]

Regeneron Pharmaceuticals, Inc.  (REGN) 
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
PDF evaluating Eylea HD (aflibercept) Injection 8 mg to treat patients with macular edema following retinal vein occlusion (RVO). The intended patient population includes th [Read more]